Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: example from an Israeli healthcare worker cohort.
Open Access
- 9 April 2022
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 120, 22-24
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy StudyMicrobiology Spectrum, 2022
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 MonthsNew England Journal of Medicine, 2021
- Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysisProceedings of the National Academy of Sciences, 2021
- SARS-CoV-2 Infection Detection by PCR and Serologic Testing in Clinical PracticeJournal of Clinical Microbiology, 2021
- Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UKEmerging Infectious Diseases, 2021
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational studyThe Lancet, 2021
- Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021Eurosurveillance, 2021
- Interpreting Diagnostic Tests for SARS-CoV-2JAMA, 2020